Top news
The Rescheduling of Cannabis: What It Means, Next Steps, and Implications for Industry
By Elizabeth Trentacost, Evelina J. Norwinski & Howard Sklamberg
Top US drug agency a notable holdout in Biden's push to loosen federal marijuana restrictions
By Jim Mustian
Week in Review
Are The Illicit Market, Curaleaf And Trulieve The 3 Biggest Winners From Rescheduling Cannabis? - Curaleaf Holdings ...
All coverage
North Carolina prosecutors weigh in on DOJ reclassification of marijuana as less dangerous drug
By Sean Coffey
A Big Bet Goes Bad
By Alan Brochstein
Marijuana reclassification: How the change in drug laws impacts Arizona
By Ashlie Rodriguez
Marijuana-specific controls in schedule III?
By Vince Sliwoski
Indiana remains one of the states with the strictest cannabis rules
By Bente Bouthier
To galvanize voters, the Biden Administration must reject half-step on marijuana reform
By Maritza Perez Medina & Kassandra Frederique
The Beginning of the End of Cannabis Prohibition
By Paul Armentano
US Congressmen Press DEA Head to Explain Her Signature Absence on Cannabis Rescheduling Document
By Tony Lange
Department of Justice Publishes Proposed Rule in Federal Register To Reclassify Cannabis
By Benjamin M. Adams
Milwaukee Leaders Announce Biden’s Marijuana Reform
By Karen Stokes
DEA Publishes Proposed Rules To Reschedule Marijuana
By Dario Sabaghi
DOJ Seeks Input On 'Unique Economic Impacts' Of Marijuana Rescheduling For 'Multibillion Dollar Industry'
By Kyle Jaeger
EXCLUSIVE: We Analyzed 4000+ DEA Marijuana Rescheduling Comments; Here's What Americans Really Think
By Javier Hasse
MSO Stocks Soar After Biden Video Confirms Cannabis Is Moving to Schedule III
By Benjamin M. Adams